Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1999 Oct 26;96(22):12708-12.
doi: 10.1073/pnas.96.22.12708.

Humoral response to herpes simplex virus is complement-dependent

Affiliations

Humoral response to herpes simplex virus is complement-dependent

X J Da Costa et al. Proc Natl Acad Sci U S A. .

Abstract

The complement system represents a cascade of serum proteins, which provide a major effector function in innate immunity. Recent studies have revealed that complement links innate and adaptive immunity via complement receptors CD21/CD35 in that it enhances the B cell memory response to noninfectious protein antigens introduced i.v. To examine the importance of complement for immune responses to virus infection in a peripheral tissue, we compared the B cell memory response of mice deficient in complement C3, C4, or CD21/CD35 with wild-type controls. We found that the deficient mice failed to generate a normal memory response, which is characterized by a reduction in IgG antibody and germinal centers. Thus, complement is important not only in the effector function of innate immunity but also in the stimulation of memory B cell responses to viral-infected cell antigens in both blood and peripheral tissues.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Classical pathway complement and complement receptors CD21/CD35 are required for the humoral response to replication-defective HD-2 virus or replication-competent KOS1.1 wt virus. Mice were injected at days 0 and 21 with 2 × 106 pfu of replication-defective (AC) or replication-sufficient (D) virus, HD-2 and KOS1.1, respectively. Antibody titers were determined by ELISA assay. Mean titer ± SD represents at least five mice analyzed in two separate experiments. (A) Deficiency in either C3 or C4 results in an impaired secondary humoral response to infectious HSV-1. (B) Cr2−/− mice have an impaired secondary response similar to mice deficient in C3. (C) Humoral response to recombinant virus-expressed heterologous protein (β-galactosidase) is also impaired in mice deficient in C3 or CD21/CD35. (D) Secondary humoral response to replication-sufficient HSV-1 (strain KOS1.1) depends on complements C3 and C4.
Figure 2
Figure 2
T cells are primed in C3−/− and Cr2−/− mice infected with HSV-1 strain HD-2. CD3+ T cells were purified by negative selection from LNs of complement-deficient or wt mice 7 days after a third challenge with virus and cultured with peritoneal macrophages along with varying concentrations of either viral lysate (Upper) or β-galactosidase (Lower). Columns represent mean ± SD of thymidine incorporation in cell lysate after harvest at day 3. Asterisk indicates statistical significance at P < 0.05.
Figure 3
Figure 3
Germinal center response is impaired in C3−/− mice after infection with 2 × 106 pfu of HSV-1 (HD-2 strain). LN (inguinal and popliteal) were harvested from either wt or C3−/− mice 7 days after a third viral challenge (A and B) or from those that were unimmunized (C and D). Cryosections were prepared and treated with antibody specific for B220 (B cell-specific) (in blue) and peanut agglutinin (crimson) as described in Materials and Methods. Representative sections identify PNA + GC in LN follicles of wt (A) but not C3−/− (B) mice infected with HSV or noninfected mice (C and D). [×100 (A and B) and ×50 (C and D).]
Figure 4
Figure 4
Replication of HSV is unimpaired in C3 knockout mice. Wt or C3−/− mice were infected with 2 × 106 pfu of KOS1.1 by corneal infection. Virus replication was determined by titering eye swabs collected at the indicated times postinfection.

References

    1. Ezekowitz R, Sim R, Hill R, Gordon S. J Exp Med. 1983;159:244–260. - PMC - PubMed
    1. Cooper N R, Nemerow G R. J Invest Dermatol. 1985;85:39–46. - PubMed
    1. Muller-Eberhard H J. Annu Rev Biochem. 1988;57:321–347. - PubMed
    1. Reid K B M, Porter R R. Annu Rev Biochem. 1981;50:433–464. - PubMed
    1. Cooper N R. Immunol Today. 1991;12:327–331. - PubMed

Publication types

LinkOut - more resources